Resmed Inc. buy JPMorgan Chase & Co.
Start price
09.01.24
/
50%
€164.95
Target price
09.01.25
€178.27
Performance (%)
20.06%
Price
09:30
€197.15
Summary
This prediction is currently active. The prediction currently has a performance of 20.06%. A total of €0.89 was paid as dividends for this prediction. This prediction currently runs until 09.01.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Resmed Inc. | -1.172% | -1.172% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $160.00 to $195.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat